Correlation between Plasma Carnitine, Muscle Carnitine and Glycogen Levels in Maintenance Hemodialysis Patients
Alicja Dębska‐Ślizień(Gdańsk Medical University), Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), J. Prajs(Gdańsk Medical University), D Kunicka(Gdańsk Medical University), Sylwia Małgorzewicz(Gdańsk Medical University), Aleksandra Kawecka(Gdańsk Medical University), Zbigniew Zdrojewski(Gdańsk Medical University), Wieslawa Lysiak‐Szydlowska(Gdańsk Medical University), J Lipinski, Klaudiusz Wojnarowski(Gdańsk Medical University)
Cited by 39
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869